Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Renal osteodystrophy.

Martin Haas1

  • 1Division of Nephrology and Dialysis, Department of Internal Medicine III, University Hospital Vienna, Vienna, Austria. martin.haas@akh-wien.ac.at

Wiener Medizinische Wochenschrift (1946)
|April 27, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of precalculated attenuation correction map for preclinical cardiac PET/MR using a <sup>1</sup>H/<sup>23</sup>Na surface coil.

EJNMMI physics·2026
Same author

Assessing PET performance, image quality, and attenuation correction in the presence of RF coils within a 9.4 T MRI for preclinical simultaneous imaging.

EJNMMI physics·2025
Same author

Quantitative accuracy of preclinical in ovo PET/MRI: influence of attenuation and quantification methods.

EJNMMI physics·2025
Same author

Characterization of FGFR signaling in prostate cancer stem cells and inhibition via TKI treatment.

Oncotarget·2021
Same author

Influence of Intratumor Microbiome on Clinical Outcome and Immune Processes in Prostate Cancer.

Cancers·2020
Same author

Characterization of iPS87, a prostate cancer stem cell-like cell line.

Oncotarget·2020
Same journal

Necrotizing fasciitis of the thigh-a devastating sign of intestinal perforation.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Regenerative therapies in rehabilitation with interfaces with occupational medicine, geriatrics, and oncology: the example of extracorporeal shock wave therapy.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Cerebral toxoplasmosis in patients with peripheral B-cell lymphoma : A case series and a literature review.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Post-pandemic rebound of rotavirus and adenovirus in pediatric gastroenteritis: a 6-year antigen-based surveillance study from Turkey.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Neuroaxis involvement in Chikungunya virus infection: a retrospective case series.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

A complicated case of a spinal Scedosporium apiospermum infection with a favorable outcome-case report.

Wiener medizinische Wochenschrift (1946)·2026
See all related articles

Renal osteodystrophy (ROD) involves bone lesions in chronic kidney disease, worsening over time and increasing fracture risk. Early diagnosis and new treatments like calcimimetics and non-absorbable phosphate binders are crucial for managing ROD.

Area of Science:

  • Nephrology
  • Endocrinology
  • Bone Metabolism

Background:

  • Chronic renal failure leads to renal osteodystrophy (ROD), characterized by bone lesions.
  • ROD is influenced by mineral metabolism, drug use, and disease progression, often worsening with dialysis and post-transplant.
  • ROD contributes to vascular calcification and impacts patient survival.

Purpose of the Study:

  • To highlight the importance of early diagnosis and management of renal osteodystrophy.
  • To discuss the impact of ROD on bone health, vascular calcification, and patient prognosis.
  • To review evolving treatment strategies for renal osteodystrophy.

Main Methods:

  • Review of existing literature on renal osteodystrophy.
  • Analysis of factors influencing ROD development and progression.

Related Experiment Videos

  • Evaluation of current and emerging therapeutic interventions.

    • Main Results:

    • ROD involves four types of bone lesions and can manifest early in renal disease.
    • ROD progresses with declining kidney function and is linked to increased fracture risk and vascular calcification.
    • New treatments offer improved management of mineral metabolism and bone health.

    Conclusions:

    • Early detection and intervention are vital for managing renal osteodystrophy.
    • Novel therapies, including non-absorbable phosphate binders and calcimimetics, show promise.
    • Addressing ROD is essential for improving long-term outcomes in chronic kidney disease patients.